Autolus Therapeutics plc
AUTL
$2.03
-$0.08-3.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.99% | -21.35% | -30.30% | 16.81% | 2.65% |
| Total Depreciation and Amortization | 21.45% | 25.03% | 27.19% | 24.90% | 26.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,933.39% | 246.40% | 52.11% | -73.96% | -102.86% |
| Change in Net Operating Assets | 49.60% | -84.03% | -119.78% | -1,888.94% | -333.66% |
| Cash from Operations | 14.22% | -13.26% | -37.47% | -31.58% | -67.94% |
| Capital Expenditure | 80.33% | 54.72% | 13.73% | -149.52% | -732.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 191.48% | 177.31% | 147.65% | -- | -- |
| Cash from Investing | 180.19% | 169.26% | 140.16% | -2,405.42% | -8,104.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.44% | -- | -- | -100.00% | -99.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -126.60% | -123.03% | -111.13% | 205.94% | 225.70% |
| Cash from Financing | -126.42% | -122.77% | -100.74% | -95.09% | -94.74% |
| Foreign Exchange rate Adjustments | -159.03% | -83.67% | 2,505.75% | -168.15% | 1,145.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.18% | 105.31% | -968.26% | -242.13% | -245.72% |